Insulin resistance in the St. Thomas' mixed hyperlipidaemic (SMHL) rabbit, a model for familial combined hyperlipidaemia

Atherosclerosis

Volumn 156, Issue 2, 2001, Pages 249-254

  De Roos, Baukje ^a   Caslake, Muriel J ^a   Ardern, Hazel A ^a   Martin Benson, G ^b   Suckling, Keith E ^b   Packard, Chris J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Hyperlipidaemia; Insulin response; Plasma triglycerides

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; DIET RESTRICTION; FAMILIAL HYPERLIPEMIA; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; GLUCOSE TOLERANCE TEST; HYPERINSULINISM; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; MALE; PROBABILITY; RABBITS; RADIOIMMUNOASSAY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0035005320     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00614-6     Document Type: Article

References (34)

1. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
2. Familial combined hyperlipidemia workshop
3. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia
4. LDL physical and chemical properties in familial combined hyperlipidemia
5. Inherited susceptibility determines the distribution of dense low density lipoprotein subfraction profiles in familial combined hyperlipidemia
6. Hereditary hyperlipidemia in the rabbit due to overproduction of lipoproteins. I. Biochemical Studies
7. Apolipoprotein B overproduction by the perfused liver of the St. Thomas' mixed hyperlipidemic (SMHL) rabbit
8. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridemia
9. Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver
10. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hypercholesterolemia
11. Impaired chylomicron remnant clearance in familial combined hyperlipidemia
12. Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives
13. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia
14. Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group
15. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension
16. Familial combined hyperlipidemia and abnormal LPL
17. Insulin resistance observed in WHHL rabbits (letter)
18. Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits
19. Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits
20. Plasma lipids and atherosclerosis in Froxfield mixed hyperlipidaemic(previously St. Thomas Hospital) rabbits
21. Insulin resistance and lipid metabolism
22. Metabolic basis of hypotriglyceridemic effects of insulin in normal men
23. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM
24. Prospective analysis of the insulin-resistance syndrome (syndrome X)
25. Does familial hypertriglyceridemia predispose to NIDDM?
26. Altering triglyceride concentrations changes insulin-glucose relationships in hypertriglyceridemic patients. Double-blind study with gemfibrozil with implications for atherosclerosis
27. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia
28. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?
29. Non-esterified fatty acid metabolism and postprandial lipaemia
30. Novel genes for familial combined hyperlipidemia
31. Mapping a gene for combined hyerlipidaemia in a mutant mouse strain
32. A mouse model with features of familial combined hyperlipidemia
33. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23
34. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians